reply Global new crown vaccine companies to increase production capacity of many countries to order Chines

In the context of the global epidemic has not been effectively controlled, the new crown vaccine has been approved in many countries, and vaccination has also been put on the agenda.As China's first new crown vaccine was approved to market with conditions, the country announced that the new crown vaccine was free for all people, and the number of people receiving the new crown vaccine gradually increased. More than 10 million doses of the novel Coronavirus vaccine have been administered to key populations since December 15, 2020, according to a press conference held by the State Council's joint prevention and control mechanism on Jan. 13.It is worth mentioning that China's new crown vaccine has been ordered by several countries. The Indonesian Drug and Food Administration announced on January 11 that it has granted an emergency license for the use of China's Xinguan vaccine, Xinhua News Agency reported on January 13. More than a dozen countries have already announced orders for China's new crown vaccine.It is important to note that stopping the spread of the epidemic through new crown vaccination requires an adequate supply of vaccine. According to the effectiveness of the new crown vaccine in China, how many people need to be vaccinated to form an immune barrier? What is the current capacity of companies behind the huge increase in demand for new crown vaccines? To this, the reporter undertook multi - party interview.The new crown vaccine was inoculated in batchesWhen to vaccinate the new crown vaccine is becoming the focus of social attention.At the end of 2020, the new coronal inactivated vaccine (Vero cells) developed by Sinopharmaceutical China Bio-Beijing Institute of Biological Products (hereinafter referred to as Sinopharmaceutical Beijing Institute) was approved for the market with conditions. A person who works in Beijing's Dongcheng District told reporters: "The company has organized the first injection of the new crown vaccine, and there is no adverse reaction."How many people need to be vaccinated with the new crown vaccine to have an immune barrier effect during repeated outbreaks? Hu Shanlian, a professor at the School of Public Health of Fudan University, told reporters that vaccines belong to active immunity, and raising the level of herd immunity is to hope that as many people as possible can be vaccinated. General vaccines, such as Class I vaccines, are expected to reach more than 95 percent of the population. In addition, the effectiveness of the vaccine -- the probability of producing synthetic antibodies -- is also important. Simply put, coverage multiplied by the probability of producing synthetic antibodies gives a rough idea of the proportion of people who will become immune. "If 72 percent of 100 people become immune, then the remaining 28 percent are much less likely to become infected," he said.Hu Shanlian told reporters: "China is currently vaccinating the new crown vaccine in batches, starting with nine key groups of people."At present, our country has 15 new vaccine approved to carry out clinical trials, including five vaccines into phase III clinical trials, in addition to the national medicine in Beijing are inactivated vaccines for conditional approal, and wuhan and Beijing branch of zhongshan d by 2 or more inactivated vaccines, Kang Xinuo adenovirus vector vaccine and recombinant subunit vaccine of dragon division horse.In Hu's view, other vaccines will be approved for the domestic market as clinical data are released.January 14, the company said to reporters: "the news company will be announced."Many countries order Chinese vaccinesThe latest data from the WHO website showed that the number of confirmed cases worldwide had increased by 593,409 from the previous day to 9,0335,008 as of 18:51 European Central Time (1:51 Beijing Time). The number of deaths increased by 12,295 to 1954,336.On January 11, Bruce Aylward, senior adviser to the WHO director-general, said that more than 40 countries have started vaccinating against the new crown vaccine, but all are high-income and upper-middle-income countries. WHO will accelerate the delivery of the new crown vaccine to low - and middle-income countries through the COVID-19 vaccine implementation programme, where vaccination is expected to begin in February.Mr Hu told reporters that most of the vaccines developed by Pfizer and Biontech were ordered by developed countries. In addition to meeting domestic demand, China's new crown vaccine also needs to be exported to support other countries.Recently, many countries ordered and vaccinated China's new crown vaccine news caused concern. Since last December, more than a dozen countries, including the United Arab Emirates, Bahrain, Morocco, Pakistan, Turkey, Argentina, Egypt, Brazil, Thailand, Mexico and Peru, have signed orders with China for the new vaccine. Jordan has officially launched a nationwide vaccination campaign for new crown vaccines since January 13, the first batch of which included vaccines from Sinopharm, CCTV News reported. In addition, Turkey issued a public notice on January 13 to approve the emergency use of the new crown vaccine from China, the first of its kind approved in Turkey.Capacity supply remains the big testBased on current production capacity of new crown vaccines, it is clear that global vaccination demand cannot be met.Biontech, which is partnered with Pfizer to develop the new crown vaccine, announced at JPMorgan Healthcare's annual conference on January 11, 14 that it will increase its capacity to 2 billion doses by 2021; Separately, another maker of the new vaccine, Moderna, and Johnson & Johnson, have set capacity targets of 600 million to 1 billion doses and close to 1 billion doses, respectively.At the same time, China's new crown vaccine production capacity is also gradually increasing. According to the data of the Ministry of Industry and Information Technology, three enterprises, including Sinoptic Beijing Branch, Wuhan Branch and Beijing Kexing Zhongwei Company, have started the "accelerated" mode. By the end of 2020, the production capacity of Sinoptic Beijing Institute will exceed 100 million doses, and by the end of 2021, it will reach more than 1 billion doses. Wuhan Institute and Beijing Kexing Zhongwei Company have also completed the construction of new crown vaccine production lines, which will significantly increase the production of vaccine and ensure the demand for new crown vaccine vaccination.Feng Duojia, president of the China Vaccine Industry Association, said in a recent interview that the four companies in Phase III clinical trials are ready for large-scale production, as soon as the clinical trials are completed and the market approval is obtained. According to the estimation of the overall production capacity of the vaccine industry in China, there is not much restriction in the large-scale production stage of the new crown vaccine.The potential market space generated by the vaccine has also attracted the attention of the capital market at the time of mass vaccination of the new crown vaccine. Under a prepurchase agreement with the government, Moderna expects to deliver 600 million to 1 billion doses of its vaccine by 2021, which would bring the company's vaccine-related sales to $11.7 billion this year, the company said Monday at JPMorgan Healthcare's annual meeting, according to media reports.In Hu's opinion, the vaccine industry has a good future, especially the new crown vaccine. Generally speaking, vaccines have specific targets for vaccination, but now the risk of Covid-19 epidemic is relatively high, and the vaccination demand is also large in not only the Chinese market, but also in the international market. If it is done well, the development prospect will be great.